APA (7th ed.) Citation

M, P. M., D, B., B, T., A, G., JB, P., D, B., . . . JM, F. (2021). TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer. Clinical genitourinary cancer, 19(6), 501. https://doi.org/10.1016/j.clgc.2021.08.008

Chicago Style (17th ed.) Citation

M, Pujalte Martin, et al. "TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer." Clinical Genitourinary Cancer 19, no. 6 (2021): 501. https://doi.org/10.1016/j.clgc.2021.08.008.

MLA (9th ed.) Citation

M, Pujalte Martin, et al. "TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer." Clinical Genitourinary Cancer, vol. 19, no. 6, 2021, p. 501, https://doi.org/10.1016/j.clgc.2021.08.008.